Literature DB >> 11278539

Copper converts the cellular prion protein into a protease-resistant species that is distinct from the scrapie isoform.

E Quaglio1, R Chiesa, D A Harris.   

Abstract

Several lines of evidence have suggested that copper ions play a role in the biology of both PrP(C) and PrP(Sc), the normal and pathologic forms of the prion protein. To further investigate this intriguing connection, we have analyzed how copper ions affect the biochemical properties of PrP(C) extracted from the brains of transgenic mice and from transfected cells. We report that the metal rapidly and reversibly induces PrP(C) to become protease-resistant and detergent-insoluble. Although these two properties are commonly associated with PrP(Sc), we demonstrate using a conformation-dependent immunoassay that copper-treated PrP is structurally distinct from PrP(Sc). The effect of copper requires the presence of at least one of the five octapeptide repeats normally present in the N-terminal half of the protein, consistent with the idea that the metal alters the biochemical properties of PrP by directly binding to this region. These results suggest potential roles for copper in prion diseases, as well as in the physiological function of PrP(C).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278539     DOI: 10.1074/jbc.M009666200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

Review 1.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

2.  RNA and CuCl2 induced conformational changes of the recombinant ovine prion protein.

Authors:  Meili Liu; Shan Yu; Jianmin Yang; Xiaomin Yin; Deming Zhao
Journal:  Mol Cell Biochem       Date:  2006-07-20       Impact factor: 3.396

3.  A mechanism for copper inhibition of infectious prion conversion.

Authors:  Daniel L Cox; Jianping Pan; Rajiv R P Singh
Journal:  Biophys J       Date:  2006-05-12       Impact factor: 4.033

Review 4.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

5.  Molecular features of the copper binding sites in the octarepeat domain of the prion protein.

Authors:  Colin S Burns; Eliah Aronoff-Spencer; Christine M Dunham; Paula Lario; Nikolai I Avdievich; William E Antholine; Marilyn M Olmstead; Alice Vrielink; Gary J Gerfen; Jack Peisach; William G Scott; Glenn L Millhauser
Journal:  Biochemistry       Date:  2002-03-26       Impact factor: 3.162

6.  The Rich Electrochemistry and Redox Reactions of the Copper Sites in the Cellular Prion Protein.

Authors:  Feimeng Zhou; Glenn L Millhauser
Journal:  Coord Chem Rev       Date:  2012-05-04       Impact factor: 22.315

Review 7.  Role of lipid in forming an infectious prion?

Authors:  Fei Wang; Jiyan Ma
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-04-12       Impact factor: 3.848

8.  Biophysical and morphological studies on the dual interaction of non-octarepeat prion protein peptides with copper and nucleic acids.

Authors:  Juliana A P Chaves; Carolina Sanchez-López; Mariana P B Gomes; Tháyna Sisnande; Bruno Macedo; Vanessa End de Oliveira; Carolina A C Braga; Luciana P Rangel; Jerson L Silva; Liliana Quintanar; Yraima Cordeiro
Journal:  J Biol Inorg Chem       Date:  2014-02-21       Impact factor: 3.358

Review 9.  Copper and the prion protein: methods, structures, function, and disease.

Authors:  Glenn L Millhauser
Journal:  Annu Rev Phys Chem       Date:  2007       Impact factor: 12.703

10.  Ligand binding promotes prion protein aggregation--role of the octapeptide repeats.

Authors:  Shuiliang Yu; Shaoman Yin; Nancy Pham; Poki Wong; Shin-Chung Kang; Robert B Petersen; Chaoyang Li; Man-Sun Sy
Journal:  FEBS J       Date:  2008-11       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.